Avoiding Campaign Launch Delays in Cosmetics Development: What Really Makes Timelines Predictable
Avoiding Campaign Launch Delays in Cosmetics Development: What Really Makes Timelines Predictable
12 min read
CEO & Founder at Labtree GmbH
Launch delays in cosmetics development rarely stem from individual mistakes, but rather from the accumulation of small handoffs. What makes deadlines predictable are structural anchors.
Topics on this page
The topic is short and compact
Launch delays usually arise from the accumulation of small, sequential handovers.
A real formulation basis as a starting point shortens the briefing phase by two to three weeks.
Standard samples within 24 hours replace late sampling and reduce sampling loops.
Delays occur in five recurring areas, the waiting times of which add up:
Briefing phase: Without a real formulation basis, the briefing remains abstract, and definition loops cost two to four weeks
sampling: Initial samples after week 6 or later mean decisions are made at the conceptual level, and requests for adjustments after receiving samples cost an additional two to six weeks
Stability & skin compatibility: Stability tests objectively take several weeks; iterations cost multiples
Approval: PIF, CPNP notification, and safety assessment take time; with sequential processing at the end, anomalies lead to formulation adjustments, which in turn require new stability testing
Production: If manufacturability is only checked at the end, late adjustments are costly
Every single one of these areas can delay a project by months. The structural anchors aim to reduce all of them simultaneously.
Where delays in cosmetics development occur
Delays occur in five recurring areas, the waiting times of which add up:
Briefing phase: Without a real formulation basis, the briefing remains abstract, and definition loops cost two to four weeks
sampling: Initial samples after week 6 or later mean decisions are made at the conceptual level, and requests for adjustments after receiving samples cost an additional two to six weeks
Stability & skin compatibility: Stability tests objectively take several weeks; iterations cost multiples
Approval: PIF, CPNP notification, and safety assessment take time; with sequential processing at the end, anomalies lead to formulation adjustments, which in turn require new stability testing
Production: If manufacturability is only checked at the end, late adjustments are costly
Every single one of these areas can delay a project by months. The structural anchors aim to reduce all of them simultaneously.
Anchor 1: formulation basis as a clear starting point
The briefing phase is structurally shortened as soon as it is not conducted in the abstract, but rather on a real formulation basis. When brands see early on which product base fits, which adjustments are necessary, and which development path is realistic, many loops of concretization are eliminated.
At Labtree, over 1,000 of our own formulations serve as the starting point for white-label, private-label, and custom product developments. Instead of an open-ended search, a concrete path is available from day one.
Effect: The briefing phase is typically two to three weeks shorter than in processes without a formulation anchor. This is time that no longer needs to be made up.
Anchor 2: Early patterns within 24 hours
sampling delays occur when the waiting time for the first physical sample is long and adjustments after receipt create further waiting times. Speed in sampling is therefore a direct lever on the overall timeline.
At Labtree, standard samples of pre-qualified formulations are dispatched from the sample warehouse within 24 hours. Shipping is free of charge for customers. This shifts the point at which the product can be physically evaluated to the first few days instead of the first few months.
Effect: Requests for adjustments are formulated early, based on real samples. Late sampling loops, which are often necessary after concept paper discussions, are eliminated.
Anchor 3: Parallel implementation instead of sequential handovers
A key lever for delays lies in the sequence. If packaging selection only starts after the final formulation has been determined and regulatory issues are only addressed after final packaging, waiting times accumulate linearly. Early, parallel consideration of these issues reduces the overall duration because they are not pursued sequentially but rather in tandem.
Concretely, this means:
Packaging selection early and parallel to sampling: Compatibility with texture and requirements is tested early on
Design parallel to customization: Design requirements flow into the packaging selection
Regulatory preparation parallel to prototyping: Preparatory steps for safety assessment and PIF run parallel to formulation development, with final approval taking place after the formulation is completed
Keep production capability in mind early in prototyping: Scaling questions are already prepared during development instead of being answered only at the end
Effect: The overall timeline becomes significantly shorter than with sequential processing; with formulation-based development involving early parallel consideration, an acceleration of up to 50 percent is realistic.
Anchor 4: Consider production capability early on
The most critical moment in a project is often the transition from development to production. If producibility is only tested at the end, late adjustments can derail the planned timeline. A formulation that is stable in the laboratory can show additional requirements under production conditions. Packaging that works on a small-scale may require adjustments in the filling system.
Structurally, the transition is mitigated by preparing scaling questions during prototyping instead of addressing them only after development is complete. In practice, this means that production is involved early in the prototype stage, and fillability, batch sizes, and process parameters are defined early on.
Effect: The step into production is coordinated. Delays at the end of a project, which are commercially particularly expensive, become significantly rarer.
In-depth sources: The legal basis for all cosmetic products marketed in the EU is the EU Cosmetics Regulation (EC) No. 1223/2009. The health assessment of ingredients in Germany lies with the Federal Institute for Risk Assessment (BfR). Industry information and market data are published by the German Cosmetic, Toiletry, Perfumery and Detergent Association (IKW).
Realistic timelines: what is possible and what is not
Even with all four anchors, physical and regulatory limits remain. Realistic timeframes:
White-label products with standard packaging: 2 to 3 months
Custom new developments: 3 to 6 months
Complex product lines (multiple products, many variants): 6 to 9 months
Three objective factors are key and cannot be compressed arbitrarily:
Stability tests: Accelerated and real-time stability objectively require time
Regulatory approvals: Safety assessment and CPNP notification have minimum turnaround times
Raw material and packaging availability: Delivery times can only be shortened to a limited extent
The structural anchors aim to overlap the waiting times in these areas rather than letting them accumulate.
Related articles: Making launch dates predictable · Reducing coordination loops · Why cosmetic projects fail
An established skincare brand wanted to expand its portfolio to include a complete make-up line. The launch date was set, and the complexity was high: multiple products, color shades, formulation variants, packaging, and approvals in parallel.
What made the on-time launch possible was not primarily project management, but the structural organization:
Early translation of the make-up expansion into concrete, actionable product and formulation paths
Structured breakdown into variants, shades, batches, packaging, and approvals
Parallel implementation of formulation, packaging, design, and registration
Coordinated transition into production
Result: Five make-up products developed and produced in six months. Launch on time despite the high complexity.
Some risks remain outside the processual lever:
Raw material bottlenecks: If an active ingredient is temporarily unavailable, an alternative selection is necessary
Regulatory changes: New requirements during development can force adjustments
Packaging availability: Lead times for specific containers can lengthen
Strategic adjustments on the brand side: When requirements change, a reset is part of reality
These factors cannot be completely avoided by any process. The realistic goal is therefore not "zero delay", but to set the structural anchors in such a way that the residual risk remains limited to what is beyond control.
The structural anchors depend significantly on the setup of the development partner. What to watch out for:
Does an independent formulation database exist as a starting point? How many formulations are documented as available?
Is there an in-house laboratory and development expertise? Are adjustments made in-house or outsourced externally?
How fast is the sampling? Is the standard 24 hours or several weeks?
Are packaging, design, and regulatory approval processed in parallel? Or is the process set up sequentially?
When is production feasibility verified? During prototyping or only at the very end?
These points determine the probability of an on-time launch more strongly than the project management setup.
More useful links
FAQ
Does Labtree have its own laboratory?
Yes. Labtree has its own development expertise, including a laboratory. This means that formulations can not only be selected, but specifically developed, tested, and adjusted. Additionally, smaller test batches can be produced in-house in order to validate products early on in real conditions and safely transfer them to production.
How long does cosmetic development typically take?
White-label products with standard packaging can be implemented in 2 to 3 months. Individual new developments require 3 to 6 months. Complex product lines can take 6 to 9 months. Crucial factors are stability tests, regulatory approvals, and the availability of raw materials and packaging.
When will I receive physical samples?
Standard samples of pre-qualified formulations are dispatched from the sample warehouse within 24 hours. Shipping is free of charge for customers. This ensures that decisions are based on real products, not on theoretical concepts.
Can the time-to-market really be reduced by up to 50 percent?
Yes. In the case of formulation-based development with parallel implementation of packaging, design, approval, and production, an acceleration of this magnitude compared to classic sequential processes is realistic. The acceleration does not result from taking shortcuts, but from parallel workflows and existing formulation bases.
Which factors cannot be compressed indefinitely?
Stability tests objectively take time, regulatory approvals have minimum lead times, and raw material and packaging availability have delivery lead times. The structural anchors aim to overlap these waiting times, not eliminate them.
What does a timely market launch cost?
Punctuality is primarily a question of structural alignment, not the size of the budget. The essential levers, formulation basis, sampling speed, parallel implementation, are part of a structured development process, not options to be purchased additionally.
Now discover more articles
